Literature DB >> 1799897

[Cardiovascular adaptation during cycloergometric exercise test in insulin-dependent diabetics with or without autonomic cardiopathy].

L Irace1, D Iarussi, S Langella, L Santangelo, V Coppola, A Iacono.   

Abstract

Sixty patients with type I diabetes mellitus underwent an ergometric stress test (EST) to evaluate the relationship between cardiac autonomic neuropathy (CAN) and hemodynamic changes during EST. All patients were divided into 2 groups: in the Group A were included 26 patients (mean age 43 +/- 9 years) with impairment of 2 or more autonomic tests according to Ewing (patients with CAN) and in the Group B were included 34 patients (mean age 38 +/- 13 years) without CAN. The EST was symptom-limited and performed with load increases of 25 W every 3 min. No positive EST were observed in both groups. Heart rate (HR) at rest and systolic blood pressure (SBP) at maximum common workload were significantly higher in Group A than in Group B. Moreover, a significant linear correlation was found between a CAN score and SBP x HR product at rest and at maximal workload. These findings are correlated with increased sympathetic activity due to a parasympathetic impairment. The data show the relationship between hemodynamic changes during EST and the Ewing test used in the diagnosis of CAN.

Entities:  

Mesh:

Year:  1991        PMID: 1799897

Source DB:  PubMed          Journal:  Cardiologia        ISSN: 0393-1978


  2 in total

1.  Left ventricular performance and autonomic dysfunction in patients with long-term insulin-dependent diabetes mellitus.

Authors:  L Irace; D Iarussi; I Guadagno; M A Tedesco; B Perna; G Ratti; P Spadaro; G Rogliani; V Armentano; A Iacono
Journal:  Acta Diabetol       Date:  1996-12       Impact factor: 4.280

2.  Cardiovascular response to exercise in diabetic patients: influence of autonomic neuropathy of different severity.

Authors:  P Bottini; C Tantucci; L Scionti; M L Dottorini; E Puxeddu; G Reboldi; G B Bolli; G Casucci; F Santeusanio; C A Sorbini
Journal:  Diabetologia       Date:  1995-02       Impact factor: 10.122

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.